Synergistic anti-inflammatory effects of low doses of curcumin in combination with polyunsaturated fatty acids: Docosahexaenoic acid or eicosapentaenoic acid

Biochemical Pharmacology

Volumn 79, Issue 3, 2010, Pages 421-430

  Saw, Constance Lay Lay ^a   Huang, Ying ^a   Kong, Ah Ng ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Curcumin; Docosahexaenoic acid; Eicosapentaenoic acid; Inflammation; Nuclear factor erythroid 2 related factor 2; Synergism

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CURCUMIN; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; HEME OXYGENASE 1; ICOSAPENTAENOIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PHOSPHOLIPASE A2; PROSTAGLANDIN E2;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME INDUCTION; ENZYME INHIBITION; MACROPHAGE; MONOTHERAPY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CELL SURVIVAL; CURCUMIN; DOCOSAHEXAENOIC ACIDS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; EICOSAPENTAENOIC ACID; FATTY ACIDS, UNSATURATED; INFLAMMATION; MICE;

EID: 70449657770     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.08.030     Document Type: Article

References (39)

1. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 6917 (2002) 860-867
2. Aggarwal B.B., and Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30 2 (2009) 85-94
3. Singh S., and Aggarwal B.B. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 270 42 (1995) 24995-25000
4. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 480-481 (2001) 243-268
5. Plummer S.M., Holloway K.A., Manson M.M., Munks R.J., Kaptein A., Farrow S., et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18 44 (1999) 6013-6020
6. Teiten M.H., Reuter S., Schmucker S., Dicato M., and Diederich M. Induction of heat shock response by curcumin in human leukemia cells. Cancer Lett 279 2 (2009) 145-154
7. Balogun E., Hoque M., Gong P., Killeen E., Green C.J., Foresti R., et al. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 371 Pt 3 (2003) 887-895
8. Shen G., Xu C., Hu R., Jain M.R., Gopalkrishnan A., Nair S., et al. Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer chemopreventive agent curcumin. Mol Cancer Ther 5 1 (2006) 39-51
9. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21 4B (2001) 2895-2900
10. Villegas I., Sanchez-Fidalgo S., and Alarcon de la Lastra C. New mechanisms and therapeutic potential of curcumin for colorectal cancer. Mol Nutr Food Res 52 9 (2008) 1040-1061
11. Strimpakos A.S., and Sharma R.A. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 10 3 (2008) 511-545
12. Hatcher H., Planalp R., Cho J., Torti F.M., and Torti S.V. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65 11 (2008) 1631-1652
13. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83 Suppl. 6 (2006) 1505S-1519S
14. Calder P.C. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids 75 3 (2006) 197-202
15. Anti M., Armelao F., Marra G., Percesepe A., Bartoli G.M., Palozza P., et al. Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology 107 6 (1994) 1709-1718
16. Courtney E.D., Matthews S., Finlayson C., Di Pierro D., Belluzzi A., Roda E., et al. Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Int J Colorectal Dis 22 7 (2007) 765-776
17. Aslan A., and Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol 87 4 (1992) 432-437
18. de Kok T.M., van Breda S.G., and Manson MM. Mechanisms of combined action of different chemopreventive dietary compounds: a review. Eur J Nutr 47 Suppl. 2 (2008) 51-59
19. Liu R.H. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr 134 Suppl. 12 (2004) 3479S-3485S
20. Misko T., Schilling R., Salvemini D., Moore W., and Currie M. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 214 1 (1993) 11-16
21. Lee J., Kong M., Ayers G., and Lotan R. Interaction index and different methods for determining drug interaction in combination therapy. J Biopharm Stat 17 3 (2007) 461-480
22. Saw C.L., Olivo M., Chin W.W., Soo K.C., and Heng P.W. Transport of hypericin across chick chorioallantoic membrane and photodynamic therapy vasculature assessment. Biol Pharm Bull 28 6 (2005) 1054-1060
23. Rusca A., Di Stefano A.F., Doig M.V., Scarsi C., and Perucca E. Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers. Eur J Clin Pharmacol 65 5 (2009) 503-510
24. Siveen K.S., and Kuttan G. Role of macrophages in tumour progression. Immunol Lett 123 2 (2009) 97-102
25. Yuan A., Chen J.J., and Yang P.C. Pathophysiology of tumor-associated macrophages. Adv Clin Chem 45 (2008) 199-223
26. Dirkx A.E., Oude Egbrink M.G., Wagstaff J., and Griffioen AW. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis. J Leukoc Biol 80 6 (2006) 1183-1196
27. Lewis C.E., and Pollard J.W. Distinct role of macrophages in different tumor microenvironments. Cancer Res 66 2 (2006) 605-612
28. Coruzzi G., Venturi N., and Spaggiari S. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond. Acta Biomed 78 2 (2007) 96-110
29. Xu G.L., Liu F., Ao G.Z., He S.Y., Ju M., Zhao Y., et al. Anti-inflammatory effects and gastrointestinal safety of NNU-hdpa, a novel dual COX/5-LOX inhibitor. Eur J Pharmacol 611 1-3 (2009) 100-106
30. Wang X., Xue H., Xu Q., Zhang K., Hao X., Wang L., et al. p38 kinase/cytosolic phospholipase A2/cyclooxygenase-2 pathway: a new signaling cascade for lipopolysaccharide-induced interleukin-1beta and interleukin-6 release in differentiated U937 cells. Prostaglandins Other Lipid Mediat 86 1-4 (2008) 61-67
31. Hong J., Bose M., Ju J., Ryu J.H., Chen X., Sang S., et al. Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25 9 (2004) 1671-1679
32. Park C., Kim G.Y., Kim G.D., Choi B.T., Park Y.M., and Choi Y.H. Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells. Oncol Rep 15 5 (2006) 1225-1231
33. Park C., Moon D.O., Choi I.W., Choi B.T., Nam T.J., Rhu C.H., et al. Curcumin induces apoptosis and inhibits prostaglandin E(2) production in synovial fibroblasts of patients with rheumatoid arthritis. Int J Mol Med 20 3 (2007) 365-372
34. Handler N., Jaeger W., Puschacher H., Leisser K., and Erker T. Synthesis of novel curcumin analogues and their evaluation as selective cyclooxygenase-1 (COX-1) inhibitors. Chem Pharm Bull (Tokyo) 55 1 (2007) 64-71
35. Basaran U.N., Dokmeci D., Yalcin O., Inan M., Kanter M., Aydogdu N., et al. Effect of curcumin on ipsilateral and contralateral testes after unilateral testicular torsion in a rat model. Urol Int 80 2 (2008) 201-207
36. Shin H.J., Lee J.Y., Son E., Lee D.H., Kim H.J., Kang S.S., et al. Curcumin attenuates the kainic acid-induced hippocampal cell death in the mice. Neurosci Lett 416 1 (2007) 49-54
37. Shen S.Q., Zhang Y., Xiang J.J., and Xiong C.L. Protective effect of curcumin against liver warm ischemia/reperfusion injury in rat model is associated with regulation of heat shock protein and antioxidant enzymes. World J Gastroenterol 13 13 (2007) 1953-1961
38. Li P., Kim S.W., Li X., Datta S., Pond W.G., and Wu G. Dietary supplementation with cholesterol and docosahexaenoic acid increases the activity of the arginine-nitric oxide pathway in tissues of young pigs. Nitric Oxide 19 3 (2008) 259-265
39. Tardivel S., Gousset-Dupont A., Robert V., Pourci M.L., Grynberg A., and Lacour B. Protective effects of EPA and deleterious effects of DHA on eNOS activity in Ea hy 926 cultured with lysophosphatidylcholine. Lipids 44 3 (2009) 225-235